3rd clinical trial for gastro leakage sensor

The xBar sensor from Israel’s Exero Medical (see here previously) is about to begin a Phase 3 pivotal clinical trial in the USA and Israel. The device aims to immediately detect post-operative leakage following gastro surgery, which is fatal in 40% of affected cases.

https://nocamels.com/2024/04/life-saving-sensor-monitors-dangerous-fallout-of-stomach-surgery/

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *